SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently gripped by an extreme short squeeze, with community discussion centered on its highly constrained float and reports that a small group of institutional holders control a majority of the shares. While many traders are enjoying significant gains from the stock's parabolic ascent, others are cautioning that the rampant volatility, frequent trading halts, and the potential for a share offering or institutional profit-taking make this a high-stakes, dangerous game of musical chairs.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is experiencing a surge in trading volume and bullish sentiment driven by CFO comments confirming production ramp-ups and multiple purchase orders that validate the company's optical engine technology for hyperscale AI. Community discussions are centered on a potential short squeeze, a rejection of recent negative research reports, and mounting optimism that the stock is undergoing an institutional re-pricing phase as it transitions from a developmental play to revenue execution.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as frustrated investors grapple with a relentless semiconductor sector rally, questioning why the stock continues to bleed despite market volatility. Community discourse is heavily polarized between long-term bears betting on an inevitable bubble burst and others debating whether to capitulate or double down on their positions amid consistent downward price pressure.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to strong bullish momentum as investors shift their focus toward the company's role in inference and agentic AI workloads. The community is actively debating the stock's valuation, its potential to reach the trillion-dollar market cap club, and the technical strength of the ongoing rally.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United Airlines is experiencing significant market volatility as it navigates operational headwinds from severe winter weather, which has triggered widespread flight cancellations and put pressure on near-term revenue. Investors are closely monitoring the company's management strategy, including its recent push for premiumization and fleet investments, while also weighing concerns over rising fuel costs and the broader impact of geopolitical instability on the sector.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 ETF is experiencing high volatility as investors react to a barrage of conflicting headlines regarding peace talks, blockade status, and potential escalation in the Middle East. The community remains deeply polarized, with many traders expressing frustration over perceived market manipulation and headline-driven price swings while debating the timing of a potential deal versus a broader conflict.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant volatility as investors weigh the potential of its new CX Enterprise agentic AI platform and a major $25 billion stock buyback program against ongoing software sector pressure and AI disruption fears. While the community remains deeply divided between those viewing the stock as a deeply undervalued generational opportunity and those concerned about long-term structural threats, the primary focus remains on whether these capital-heavy initiatives will finally catalyze a definitive trend reversal.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust is experiencing heightened volatility as market participants fixate on the expiration of ceasefire talks in the Middle East and the potential for a geopolitical escalation. The community is actively debating the reliability of diplomatic headlines versus the risk of renewed conflict, with retail investors expressing frustration over the market's resilience against negative news cycles.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently in the spotlight following a strong earnings beat, where they surpassed revenue expectations and raised their full-year profit outlook. Community sentiment is mixed as bulls celebrate the stock's recovery and the announcement of a multi-billion dollar share buyback, while bears continue to scrutinize long-term healthcare cost pressures and regulatory headwinds.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

Abbott Laboratories is experiencing significant market attention following its earnings report and the strategic $23 billion acquisition of Exact Sciences. While the company faces pressure from adjusted growth guidance and ongoing litigation concerns, investors remain focused on long-term value, with many discussing the stock's potential for a re-rating as they navigate the integration of its expanded diagnostics footprint.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

AbCellera (Nasdaq: ABCL) today announced that it will disclose interim results from the Phase 1 portion of its study of ABCL635, including observed safety profile, pharmacokinetic, and...

AbCellera Biologics (NASDAQ:ABCL) Upgraded to "Strong-Buy" at JonesTrading

JonesTrading raised shares of AbCellera Biologics to a "strong-buy" rating in a research note on Thursday...

JonesTrading Begins Coverage on AbCellera Biologics (NASDAQ:ABCL)

JonesTrading initiated coverage on shares of AbCellera Biologics in a research note on Friday. They issued a "buy" rating and a $11.00 target price for the company...

Tudor Investment Corp ET AL Invests $3.67 Million in AbCellera Biologics Inc. $ABCL

Tudor Investment Corp ET AL bought a new position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL - Free Report) in the third quarter, according to the company in its most recent 13F filing with...

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

AbCellera (Nasdaq: ABCL) will announce its first quarter 2026 financial results on Monday, May 11, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the...

AbCellera Biologics Eyes Integrated Biotech Shift; ABCL635 Phase II Data Due in Q3 at Forum

AbCellera Biologics (NASDAQ:ABCL) is working to evolve from a technology-enabled drug discovery partner into what the company described as an integrated biotech with internal programs advancing through mid- to late-stage development, according to comments from Senior Director of Strategic Finance an...

AbCellera Biologics Pivots to Pipeline as ABCL635 Phase II Hot Flash Data Nears, Exec Says

AbCellera Biologics (NASDAQ:ABCL) is positioning itself as a more pipeline-driven biotechnology company after more than a decade of platform investment, according to comments from Senior Director of...

DNB Asset Management AS Buys Shares of 656,208 AbCellera Biologics Inc. $ABCL

DNB Asset Management AS purchased a new position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL - Free Report) in the third quarter, according to the company in its most recent disclosure with...

What Sparked AbCellera Biologics To Soar Over 9% After Hours

AbCellera Biologics shares jumped 9.3% after hours to $3.52 following an 83% earnings beat in Q4 2025.read more...

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates

ABCELLERA BIOLG (ABCL) delivered earnings and revenue surprises of +83.56% and +565.48%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

Current Price	$3.99
Prev Close	$3.91
Open	$3.92
Dividend Yield	0.00%
50-Day Moving Average	$3.44
Beta	1.50
Avg. Volume	2.69M
PE Ratio	-7.97

52-Week High	$6.52
52-Week Low	$1.94
Market Capitalization	$1.19B
EPS (Annual)	-$0.4901
Price to Book	1.22
Revenue Per Employee	$133,679.71

ABCL
AbCellera Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABCL News

ABCLAbCellera Biologics Inc